Medical News

RSS

BMA comment on Shipman Inquiry's recommended changes to the regulation of controlled drugs in the community

The BMA broadly welcomes proposals to change the management and regulation of controlled drugs in the latest report from the Shipman Inquiry.

15 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Some physicians express a sense of fatalism about HIV prevention

UCSF researchers have found that some physicians express a sense of fatalism about HIV prevention and this belief - that changes in sexual risk behavior by their HIV-positive patients are unlikely - is hindering the provision of prevention counseling services in publicly-funded clinics.

15 Jul 2004

Important milestone for any cancer therapy that will be useful for treating patients

Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs - and often cures - malignant melanoma, one of the most lethal forms of skin cancer and the most common cancer of young adults.

15 Jul 2004

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

At the XVth International AIDS Conference in Bangkok, Thailand, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation (LIR), will present his laboratory’s latest findings on how aberrant immune activation underlies HIV pathogenesis.

15 Jul 2004

British GPs elect new leader

Dr Hamish Meldrum, a GP practising in Bridlington, East Yorkshire, has today (Thursday 15 July 2004) been elected to lead the UK's 45,000 GPs as the new chairman of the BMA's General Practitioners Committee (GPC).

15 Jul 2004

New early breast cancer treatment significantly reduces the risk of cancer returning

Marking the first major treatment advance since tamoxifen's introduction over 25 years ago, Canada's leading oncologists and breast cancer patient support and advocacy groups gathered to applaud a new era in treatment for early breast cancer.

15 Jul 2004

Research may help predict risk for prostate cancer based on gene expression patterns

According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.

15 Jul 2004

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Scientists affiliated with the Harvard University Medical School have devised ways of bolstering patients' immune response against kidney and breast cancer.

15 Jul 2004

General childhood intelligence may be an important and informative early determinant of subsequent adult health

Intelligent children may be less likely to develop serious disease in adulthood than their less intelligent peers, suggests a long term study in the Journal of Epidemiology and Community Health.

15 Jul 2004

Dietary niacin may protect against the development of Alzheimer's disease

Dietary niacin (vitamin B3 ) may protect against the development of Alzheimer's disease and the cognitive decline associated with ageing in older people, suggests research in the Journal of Neurology Neurosurgery and Psychiatry.

15 Jul 2004

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

During the International AIDS Conference in Bangkok, IDA ARV Procurement Services BV and Clinton Foundation announced the agreement that enables developing countries to purchase high-quality AIDS medicines and diagnostics at the lowest available prices.

15 Jul 2004

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Today's prostate cancer treatments are more aggressive and successful

In recent years, doctors have become more willing to treat prostate cancer more aggressively with radiation therapy, and as a result, more patients are being cured of their cancer

15 Jul 2004

Blacks receive transplants at disproportionately low rates

Black people in the United States have reduced access to many medical therapies and liver transplantation is one area where such disparity is suspected to exist.

15 Jul 2004

Thalidomide's role in fighting blood disorders, such as multiple myeloma

From the late 1950s to the end of 1961, thalidomide was a popular sedative and treatment for morning sickness until it was discovered to cause fetal malformations, which proved fatal within the first year of life in 40 percent of affected infants.

13 Jul 2004

Investigation of glue as an embolic agent

Although embolization has been used for over 20 years to treat trauma victims with massive bleeding and to control hemorrhage after childbirth instead of emergency hysterectomy, the investigation of glue as an embolic agent is new.

13 Jul 2004

Computer-based program that assesses the health of people enrolled in a given health plan

Researchers at the Johns Hopkins Bloomberg School of Public Health have signed a multi-year agreement with PharMetrics, Inc., of Watertown, Mass., to acquire data from the company’s proprietary Anonymous Patient-Centric Database.

13 Jul 2004

Women with a condition called vulvodynia process pain differently

The researchers tested 17 women with vulvodynia and 23 similar women without pain at 23 sites throughout the vulva and at the deltoid muscle, the shin and the thumbnail to assess pain tolerance. They found the women with vulvodynia had lower tolerance at all sites than the women without vulvodynia.

13 Jul 2004

Priorities on dealing with the big 3 infectious diseases - HIV/AIDS, TB, and malaria

The author of a Viewpoint article published online by THE LANCET argues for a renewed public-health effort to tackle so-called ‘neglected diseases’ which continue to have serious impact in less-developed countries.

13 Jul 2004

Medical News

BMA comment on Shipman Inquiry's recommended changes to the regulation of controlled drugs in the community

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Some physicians express a sense of fatalism about HIV prevention

Important milestone for any cancer therapy that will be useful for treating patients

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

British GPs elect new leader

New early breast cancer treatment significantly reduces the risk of cancer returning

Research may help predict risk for prostate cancer based on gene expression patterns

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

General childhood intelligence may be an important and informative early determinant of subsequent adult health

Dietary niacin may protect against the development of Alzheimer's disease

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

Strategic analysis of the breast cancer therapeutics pipeline

Today's prostate cancer treatments are more aggressive and successful

Blacks receive transplants at disproportionately low rates

Thalidomide's role in fighting blood disorders, such as multiple myeloma

Investigation of glue as an embolic agent

Computer-based program that assesses the health of people enrolled in a given health plan

Women with a condition called vulvodynia process pain differently

Priorities on dealing with the big 3 infectious diseases - HIV/AIDS, TB, and malaria

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News